Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.40 |
| ▸ | TYMP | P19971 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | TK1 | P04183 | 4/20 | 0.35 |
| ▸ | NT5M | Q9NPB1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8816517 | 0.89 | — | — | |
| SCHEMBL8888860 | 0.82 | RNASE1 (0.42) | RNASE1TYMPALDH1A1LMNAALB | |
| SCHEMBL7868482 | 0.82 | LMNA (0.43) | LMNA | |
| SCHEMBL9223581 | 0.80 | RNASE1 (0.44) | RNASE1TYMPALDH1A1LMNAALB | |
| SCHEMBL10643586 | 0.79 | LMNA (0.41) | TYMPALDH1A1LMNAALBPOLB | |
| SCHEMBL749811 | 0.79 | RNASE1 (0.38) | RNASE1TYMPALDH1A1LMNAALB | |
| SCHEMBL8595983 | 0.78 | RNASE1 (0.39) | RNASE1TYMPALDH1A1LMNAALB | |
| SCHEMBL8771276 | 0.78 | RNASE1 (0.39) | RNASE1TYMPALDH1A1LMNAALB | |
| SCHEMBL8612661 | 0.75 | RNASE1 (0.44) | RNASE1TYMPALDH1A1LMNAALB | |
| SCHEMBL6297081 | 0.74 | PYGM (0.35) | RNASE1TYMPTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008069451-A1 | IMPROVED PROCESS FOR THE PREPARATION OF CLEVUDINE AS ANTI-HBV AGENT | BUKWANG PHARM CO., LTD. (KR) | 2008-06-12 | — | — | WO | disclosed |
| EP-1373288-A1 | PROCESS FOR THE PREPARATION OF 2'-HALO-BETA-L-ARABINOFURANOSYL NUCLEOSIDES | Triangle Pharmaceuticals Inc. (US) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002079213-A1 | PROCESS FOR THE PREPARATION OF 2'-HALO-$G(B)-L-ARABINOFURANOSYL NUCLEOSIDES | TRIANGLE PHARMACEUTICALS, INC. (US) | 2002-10-10 | — | — | WO | disclosed |
| WO-1999044646-A1 | NOVEL IMAGING AGENTS AND METHODS FOR THE PREPARATION AND USE THEREOF | UNIVERSITY ADVANCED BIO-IMAGING ASSOCIATES (US) | 1999-09-10 | — | — | WO | disclosed |